Sign in

Lost your password?
(close)

india

MNCs’ Healthcare Access Initiatives in India

With the Indian public healthcare apparatus straining at the seams to provide affordable access to treatments to the country’s vast population, two pioneering pharmaceutical multinationals – Novartis and Janssen -…

India: Creating An Innovative Healthcare Ecosystem

At the Organization of Pharmaceuticals Producers of India (OPPI), the association representing the research-based…

Africa: The Launchpad for Indian Pharma

Although most industry observers expect that Indian pharma exports to the US will pick up again in the coming…

India Healthcare: “Modicare” Lives On

Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s…

Latest Report

In Conversation

Interview: Deepak Birewar – Chairman & Founder, Inventys Research, India

Dr. Deepak Birewar, founder and chairman of the dynamically growing CDMO Inventys Research, highlights the crucial importance of innovation in the company’s strategy to outperform its competition and strengthen its relationships with leading customers globally. Whether it relates to custom manufacturing or the company’s own product portfolio, Dr. Birewar moreover reveals how Inventys has consistently been able to develop and…

Interview: Mohal Sarabhai – Managing Director, ASENCE…

Thomas Broeer – MD UK and Ireland, Aurobindo

India Pharma Market Facts & Figures Snapshot

India’s pharmaceutical sales and forecast from 2013 up to 2021. Between 2017 and 2021, the Indian pharma…

Related Report

How Beneficial Is The Recent Price Control Exemption For Innovative Drugs In…

Anay Shukla leads the pharmaceutical, life sciences, med-tech and healthcare practice at Nishith Desai Associates,…

Meeting US FDA Standards Across the Board in India

In a context where even well-established, multi-billion-dollar domestic companies have received warning letters…

India: Still a Land of Opportunity for MNCs

For multinational companies, despite ‘pharmerging markets’ not holding the hype and allure they once did, India…

India’s Drug Regulatory Reforms: Building Trust

Dilip Shah, the Secretary-General of the Indian Pharmaceutical Alliance advocates for a stronger and more…

Quality Compliance in Indian Pharma: The Learning Curve

One issue grinding the gears of the Indian pharmaceutical industry over recent years has been quality compliance.…

Indian Biosimilars: Going Global

Deloitte predicts that the global market for biosimilars will reach between USD 25 and 35 billion by 2020, driven…

India: Good Endings, Good Beginnings

What probably best explains the contrasts in the Indian pharmaceutical landscape is the fact that India can take…

10 Pharma Leaders to Know in India

Indian pharma companies provide affordable generic drugs to patients in almost all countries across the globe,…

Colombia: The Great Indian Investment Wave

With the onset of universal public healthcare, new types of foreign actors have been spying fresh opportunities to…

India: An Emerging Knowledge Superpower

“India, as a manufacturing hub, offers safe, effective, quality medicines, at the very best prices. Now, we…

Indian Contract Research Industry Set for Rapid Growth

The global pharmaceutical outsourcing market was estimated to be USD 115.7 billion in 2016, of which 49 percent is…

We use cookies to ensure that we give you the best experience on our site. For more info click here